This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cecka JM et al. (2005) Preformed cytotoxic antibodies in potential allograft recipients: recent data. Hum Immunol 66: 343–349
Gebel HM et al. (2003). Pretransplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs risk. Am J Transplant 3: 1488–1500
Karpinski M et al. (2001) Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 12: 2807–2814
Dmitrienko S et al. (2006) Sensitivity, specificity and predictive value of class I and class II anti-HLA antibodies detected by Luminex in patients undergoing renal transplantation [abstract 10-P]. Hum Immunol 67 (Suppl 1): S114
El-Awar N et al. (2005) HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 66: 989–997
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Cecka, J. Does flow cytometry crossmatch predict renal allograft outcome in patients with a negative antiglobulin crossmatch?. Nat Rev Nephrol 3, 136–137 (2007). https://doi.org/10.1038/ncpneph0405
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0405